Access Holdings, led by Aigboje Aig-Imoukhuede, backs Zambia with $100 million pledge
Access Holdings pledges $100 million to boost Zambia’s energy and agriculture, strengthening power supply and food security.
Skip to content
Access Holdings pledges $100 million to boost Zambia’s energy and agriculture, strengthening power supply and food security.
Johann Rupert’s net worth falls $1.8 billion as Richemont shares drop, despite strong luxury jewelry sales and $8.6 billion cash reserves.
ADH stock rebound lifts Anas Sefrioui’s stake above $1 billion, signaling renewed confidence in Morocco’s real estate market.
Cobus Stofberg’s stake in Naspers surged to $123 million in 2025 as the tech giant’s market value climbed above $54 billion.
Five new billionaires join Africa’s top ranks in 2025, led by gains in real estate, banking, and tech sectors.
Alex Karp’s fortune jumps to $16 billion, rising $8.9 billion on Palantir’s AI-powered software demand.
Gupta brothers’ Johannesburg homes sold for $2 million, 47 percent below their $3.64 million valuation, as part of a business rescue plan.
Malawi’s Thom Mpinganjira and Egypt’s Hisham Talaat Moustafa join Africa’s billionaire list after major stock gains in August.
Christopher Seabrooke’s Sabvest stake slips to $84 million as shares fall 14.55 percent since mid-June.
Rupen Mulchand Haria secures $3.2 million tax victory, confirming capital gains tax applies on sale date, not registration.
Dangote refinery cuts petrol price to $0.534 per liter, boosting Nigeria’s energy independence and processing 500,000 barrels daily.
Phuthi Mahanyele-Dabengwa’s Naspers stake rises to $12.4 million as shares surge, boosting Africa’s most valuable company.
Malawian banker Thom Mpinganjira’s FDH Bank shares reach $1.12 billion, making him the country’s first billionaire and richest citizen.
Thom Mpinganjira’s FDH Bank stake reaches $1.12 billion, making him Malawi’s richest man as the bank’s value surges to $2 billion in 2024.
BUA Foods tops Nigerian Exchange with $6.76 billion valuation; revenue grows 36%, net profit doubles in first half of 2025.
Gus Attridge’s Aspen Pharmacare stake drops over $12 million as shares slide 9.45%, pushing market value below $3 billion.